Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung, J Cachexia Sarcopenia Muscle, vol.10, issue.5, pp.1070-82, 2019. ,
,
Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer, J Gastric Cancer, vol.17, pp.74-87, 2017. ,
Prognostic impact of CT-quantified muscle and fat distribution before and after first-linechemotherapy in lung cancer patients, PloS One, vol.12, p.169136, 2017. ,
Marked changes in body composition following neoadjuvant chemotherapy for oesophago-gastric cancer, Clin Nutr, vol.31, pp.74-81, 2012. ,
Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer, Clin Radiol, vol.73, p.505, 2018. ,
Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index, PloS One, vol.10, p.139749, 2015. ,
The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer, J Geriatr Oncol, vol.9, 2018. ,
Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer, J Cachexia Sarcopenia Muscle, vol.9, pp.315-340, 2018. ,
Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A), Int J Clin Oncol, vol.24, issue.10, pp.1204-1217, 2019. ,
Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients, J Cachexia Sarcopenia Muscle, vol.9, 2018. ,
Loss of muscle mass during chemo-therapy is predictive for poor survival of patients with metastatic colorectal cancer, J Clin Oncol, vol.34, pp.1339-1383, 2016. ,
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab, Med Oncol, vol.29, pp.1005-1014, 2012. ,
No evi-dence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer, BMC Canc, vol.19, p.847, 2019. ,
A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy de-mands, Am J Clin Nutr, vol.89, pp.1173-1182, 2009. ,
Bone mineral density in women treated for various types of gynecological cancer, Asia Pac J Clin Oncol, vol.12, 2016. ,
As-sociation of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer, Mol Cell Endocrinol, vol.402, pp.51-57, 2015. ,
Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?, Breast Canc Res Treat, vol.123, pp.805-819, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00563446
Longitudinal assessment of bone loss from diagnostic computed tomography scans in gy-necologic cancer patients treated with chemotherapy and radiation, Am J Obstet Gynecol, vol.203, issue.353, pp.1-7, 2010. ,
The influence of chemo-therapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer, Eur J Cancer, vol.45, pp.3205-3217, 2009. ,
Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients, BMC Cancer, vol.16, p.860, 2016. ,
Cancer-associated muscle weakness: what's bone got to do with it?, Bonekey Rep, vol.4, p.691, 2015. ,
Muscleebone interactions: basic and clinical aspects, Endocrine, vol.45, pp.165-77, 2014. ,
The role of TGFb in bone-muscle crosstalk, Curr Osteoporos Rep, vol.15, pp.18-23, 2017. ,
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity, Am J Physiol Endocrinol Metab, vol.296, 2008. ,
The molecular basis of skeletal muscle atrophy-parallels with osteoporotic signaling, J Musculoskelet Neuronal Interact, vol.8, pp.340-341, 2008. ,
Adipose tissue in obesity-related inflam-mation and insulin resistance: cells, cytokines, and chemokines, ISRN Inflamm, p.139239, 2013. ,
Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity, Drug Discov Today, vol.14, pp.208-221, 2009. ,
Cross-talk between skeletal muscle and adipose tissue: a link with obesity?, Med Res Rev, vol.25, pp.49-65, 2005. ,
Chemotherapy-induced muscle wasting: association with NF-kB and cancer cachexia, Eur J Transl Myol, vol.28, issue.2, pp.158-66, 2008. ,
Cardioprotective effect of green tea extract and vitamin E on Cisplatin-induced cardiotoxicity in mice: toxicological, histological and immunohistochemical studies, Biomed PharmacoTher, vol.113, p.108731, 2019. ,
Metformin mitigates fibrosis and glucose intolerance induced by Doxorubicin in subcutaneous adipose tissue, Front Pharmacol, vol.9, p.452, 2018. ,
Prevention of chemotherapy-induced osteoporosis by cyclophosphamide with a longacting form of parathyroid hormone, J Endocrinol Invest, vol.34, 2011. ,
Value of contrast-enhanced ultrasound quantification criteria for identifying pa-tients not responding to bevacizumab-based therapy for colorectal liver me-tastases, Ultraschall Med, vol.39, pp.544-58, 2018. ,
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, vol.45, pp.228-275, 2009. ,
Defi-nition and classification of cancer cachexia: an international consensus, Lancet Oncol, vol.12, issue.10, pp.70218-70225, 2011. ,
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, vol.9, 2008. ,
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care, Appl Physiol Nutr Metab, vol.33, pp.997-1006, 2008. ,
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal crosssectional image, J Appl Physiol, vol.97, 2004. ,
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography, J Appl Physiol, vol.85, pp.115-137, 1998. ,
Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography, Clin Nutr, vol.37, pp.1707-1721, 2018. ,
Body composition measurement using computed tomography: does the phase of the scan matter?, Nutrition, vol.41, pp.37-44, 2017. ,
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, vol.31, 2013. ,
Vertebral bone density in Icelandic women using quantitative computed tomography without an external reference phantom, Osteoporos Int, vol.3, 1993. ,
Precise measurement of vertebral bone density using computed tomography without the use of an external reference phantom, J Digit Imag, vol.2, pp.31-39, 1989. ,
Asynchronously calibrated quantitative bone densitometry, J Clin Densitom, vol.20, pp.216-241, 2017. ,
Validation of asyn-chronous quantitative bone densitometry of the spine: accuracy, short-term reproducibility, and a comparison with conventional quantitative computed tomography, Sci Rep, vol.7, 2017. ,
Comparison of femoral neck BMD evaluation obtained using Lunar DXA and QCT with asynchronous calibration from CT colonography, J Clin Densitom, vol.18, pp.5-12, 2015. ,
Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD, J Clin Densitom, vol.18, pp.274-86, 2015. ,
ACR-SPR-SSR practice parameter for the per-formance of quantitative computed tomography (QCT) bone densitometry (amended 2014 resolution 39), 2008. ,
Practical manage-ment of bevacizumab-related toxicities in glioblastoma, Oncologist, vol.20, pp.166-75, 2015. ,
Bevacizumab toxicities and their management in ovarian cancer, Gynecol Oncol, vol.117, pp.497-504, 2010. ,
, Common Terminology criteria for adverse events (CTCAE) | protocol development | CTEP, p.23, 2019.
Bevacizumab pharmacokinetics influence overall and progression-free sur-vival in metastatic colorectal cancer patients, Clin Pharmacokinet, vol.55, pp.1381-94, 2016. ,
The advantages and limitations of cross-sectional body composition analysis, Curr Opin Support Palliat Care, vol.5, 2011. ,
Gender differences in volumetric bone density: a study of opposite-sex twins, Osteoporos Int, vol.14, pp.564-573, 2003. ,
Theophylline is able to partially revert cachexia in tumour-bearing rats, Nutr Metab, vol.9, p.76, 2012. ,
Cardiac muscle wasting in individuals with cancer cachexia, ESC Heart Fail, vol.4, pp.458-67, 2017. ,
Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia, J Cachexia Sarcopenia Muscle, vol.9, 2018. ,
Dif-ferential bone loss in mouse models of colon cancer cachexia, Front Physiol, vol.7, p.679, 2016. ,
Inter-tissue communi-cation in cancer cachexia, Nat Rev Endocrinol, vol.15, issue.9, 2018. ,
Comparison of areal and estimated volumetric bone mineral density values between older men and women, Osteoporos Int, vol.5, pp.271-276, 1995. ,
Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens, Cancer Med, vol.5, pp.607-623, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01881582